ATXI CIK: 1644963

Avenue Therapeutics Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY20
FY21
FY22
FY24
FY25
FY20 – FY25
(positive)
millions USD
FY20:
–
FY21:
–
FY22:
–
FY24:
–
FY25:
–
(positive)
Change from FY20 to FY25
millions USD
FY20:
−5.21
FY21:
−3.74
FY22:
−8.04
FY24:
−11.3
FY25:
−3.08
(positive)
Change from FY20 to FY24
millions USD
FY20:
−5.21
FY21:
−3.73
FY22:
−8.02
FY24:
−11.1
FY25:
–
(positive)
Change from FY20 to FY24
millions USD
FY20:
−5.15
FY21:
−3.73
FY22:
−3.60
FY24:
−11.7
FY25:
–
(positive)
Change from FY20 to FY25
millions USD
FY20:
−5.15
FY21:
−3.73
FY22:
−3.55
FY24:
−11.7
FY25:
−2.91

All amounts in millions USD Data sources:SEC EDGARTwelve Data